As of Thursday close, Roivant Sciences Ltd.’s (NASDAQ:ROIV) stock was down -$0.34, moving down -3.15 percent to $10.47. The average number of shares traded per day over the past five days has been 4,437,100 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.92 fall in that time frame. In the last twenty days, the average volume was 3,236,275, while in the previous 50 days, it was 5,532,602.
Since last month, ROIV stock retreated -9.27%. Shares of the company fell to $10.32 on 08/17/23, the lowest level in the past month. A 52-week high of $12.01 was reached on 07/18/23 after having rallying from a 52-week low of $2.87. Since the beginning of this year, ROIV’s stock price has risen by 31.04% or $2.48, and marked a new high 13 times. However, the stock has declined by -12.79% since its 52-week high.
ROIV stock investors should be aware that Roivant Sciences Ltd. (ROIV) stock had its last reported insider trading activity 4 days ago on Aug 14. Venker Eric, the Chief Operating Officer of the company, disposed of 59,811 shares for $11.89 on Aug 14. It resulted in a $711,153 divestment by the insider. Venker Eric sold 44,629 shares at an average price of $11.93 on Aug 03. The insider now owns 627,918 shares following the transaction. On Aug 03, Chief Accounting Officer Kumar Rakhi sold 3,681 shares at $12.00 apiece. The transaction was valued at $44,172.
Valuation Metrics
The stock’s beta is 1.31. Besides these, the trailing price-to-sales (P/S) ratio of 129.19, the price-to-book (PB) ratio of 6.46.
Financial Health
In the three months ended June 29, Roivant Sciences Ltd.’s quick ratio stood at 6.60, while its current ratio was 6.60, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.32, and the total debt-to-equity ratio was 0.36. On the profitability front, the trailing twelve-month gross margin is 78.60% percent. Based on annual data, ROIV earned $48.15 million in gross profit and brought in $61.28 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -72.90%. Return on equity (ROE) for the past 12 months was -86.60%.
In Roivant Sciences Ltd.’s quarter-end financial report for June 29, it reported total debt of $385.07 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. ROIV’s revenue rose 80.02% to $27.38 million during the quarter, while net income inched up to $21.62 million. While analysts expected Roivant Sciences Ltd. to report -$0.3 quarterly earnings, the actual figure was -$0.38 per share, beating the consensus estimate by -26.70%. During the quarter, the company generated -$270.57 million in EBITDA. The liabilities of Roivant Sciences Ltd. were 802.51 million at the end of its most recent quarter ended June 29.
Technical Picture
This quick technical analysis looks at Roivant Sciences Ltd.’s (ROIV) price momentum. With a historical volatility rate of 41.04%, the RSI 9-day stood at 32.30% on 17 August.
With respect to its five-day moving average, the current Roivant Sciences Ltd. price is down by -8.08% percent or -$0.92. At present, ROIV shares trade -5.93% below its 20-day simple moving average and +51.30% percent above its 100-day simple moving average. However, the stock is currently trading approximately +7.38% above its SMA50 and +99.43% above its SMA200.
Stochastic coefficient K was 14.07% and Stochastic coefficient D was 35.30%, while ATR was 0.51. Given the Stochastic reading of 8.93% for the 14-day period, the RSI (14) reading has been calculated as 40.16%. As of today, the MACD Oscillator reading stands at -0.45, while the 14-day reading stands at -0.65.
